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ABSTRACT
Alternative RNA splicing greatly increases proteome
diversity, and the possibility of studying genome-
wide alternative splicing (AS) events becomes avail-
able with the advent of high-throughput genomics
tools devoted to this issue. Kaposi’s sarcoma asso-
ciated herpesvirus (KSHV) is the etiological agent of
KS, a tumor of lymphatic endothelial cell (LEC)
lineage, but little is known about the AS variations
induced by KSHV. We analyzed KSHV-controlled AS
using high-density microarrays capable of detecting
all exons in the human genome. Splicing variants
and altered exon–intron usage in infected LEC were
found, and these correlated with protein domain
modification. The different 30-UTR used in new tran-
scripts also help isoforms to escape microRNA-
mediated surveillance. Exome-level analysis further
revealed information that cannot be disclosed using
classical gene-level profiling: a significant exon
usage difference existed between LEC and CD34
+
precursor cells, and KSHV infection resulted in
LEC-to-precursor, dedifferentiation-like exon level
reprogramming. Our results demonstrate the appli-
cation of exon arrays in systems biology research,
and suggest the regulatory effects of AS in endothe-
lial cells are far more complex than previously
observed. This extra layer of molecular diversity
helps to account for various aspects of endothelial
biology, KSHV life cycle and disease pathogenesis
that until now have been unexplored.
INTRODUCTION
Alternative pre-mRNA processing greatly increases the
complexity of eukaryotic transcriptomes and hence the
diversity of proteome. Such processing may thereby con-
tribute to species-speciﬁc and tissue-speciﬁc functions (1).
The roles of spliced RNA isoforms in tumorigenesis and
development have long been documented, in this context,
genome-wide analysis of alternative splicing (AS) events
have been impeded by difﬁculties in systematically iden-
tifying and validating transcript isoforms. Initially, most
gene expression arrays were designed to target their probes
to only a speciﬁc part of genes and thus were unable to
identify speciﬁc isoform changes. Methods of studying al-
ternative splicing using microarrays and other related bio-
informatics tools have appeared only recently, and this
advance in technology has greatly aided our understand-
ing of AS events. Microarrays using exon-junction probes
or exon-speciﬁc probes were used ﬁrst for genome-wide
analysis in yeast (2) and then to detect alternative
splicing differences in mammalian tissues; they have been
found to have a validity rates ranging from  50% (3) to
70–85% (4,5). Genome-wide analysis of AS events also led
to the new discoveries; for example, brain-speciﬁc splicing
that was researched using microarrays has revealed how a
neuronal splicing factor, Nova, shapes the synapse (6,7).
Kaposi’s sarcoma (KS) is the most common cancer in
individuals with HIV or AIDS and is one of the most
common cancers in patients who have had their immune
system suppressed (8). The epidemiology of KS, in par-
ticular its geographical distribution as well as its preva-
lence in gay men, indicated that there was an infectious
agent closely related to this neoplasm. In 1994, a new type
of human g-herpesvirus, Kaposi’s sarcoma-associated her-
pesvirus (KSHV), also known as human herpesvirus 8
(HHV8), was identiﬁed. This was done by representational
difference analysis whereby KS tissue was compared with
normal tissue from the same individual (9). Genomics
tools have been widely applied to KSHV research and
have unmasked novel KS tumorigenesis mechanisms that
cannot be readily disclosed by classical hypothesis-driven
studies (10–12). For example, transcriptome analysis
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closely resembles that of lymphatic endothelial cells (LEC),
and KSHV infection induces unexpected LEC-to-blood
vessel endothelial cell (BEC) transcriptome reprogramm-
ing (13). Many other novel discoveries have also been
obtained by array-based screening using KSHV-infected
LECs, BECs and Human umbilical vein endothelial cells
(HUVECs) (14). However, little is known at present about
whether KSHV is able to inﬂuence the global RNA
splicing pattern in infected cells, as well as the potential
outcomes of AS on endothelial cells (ECs) activities.
Another approach to understand how KSHV may con-
tribute to sarcomagenesis is to organize KSHV-regulated
genes or AS events into functional modules or signaling
pathways. Although gene expression proﬁling can reveal
differentially expressed genes, the challenge remains the
assignment of the biological signiﬁcance of these genes
within the complete biological system. Systems biology
helps to interpret the interactions between the components
of biological systems (such as KSHV-infected ECs), and
how these interactions give rise to the functional behavior
of the system. Disrupted crosstalk among biological mod-
ules can be a hallmark of cancer (15). Functional network
analysis has been widely applied to analyze the transcrip-
tomes of complex biological systems such as cancer and
stem cells (16,17). However, there has been little research
that has used genetic network tools to reveal the system
changes caused by KSHV (14). As yet there has been no
global genetic network/systems biology picture published
for KSHV-infected cells, particularly involving virus-
induced RNA isoforms. For example, how KSHV-
regulated AS events may produce profound changes in
the predicted protein domain/motif composition that
ought to affect protein function and interaction, such as
changesinthegeneticnetworking,andhowexoninclusion/
exclusion may modify the predicted microRNA binding
site composition of transcripts, remains unelucidated.
Here, we investigate KSHV-regulated endothelial tran-
scripts across their entire length using the Affymetrix
GeneChip Human Exon 1.0 ST Array, which can detect
splicing differences between various types of samples
(18,19).
MATERIALS AND METHODS
Cell culture and KSHV infection
Human dermal LECs were purchased from Promo Cell
(Heidelberg, Germany; product No. C-12217) and main-
tained for up to 10 passages in endothelial cell growth
medium MV (Promo Cell C-22020) in a humidiﬁed incu-
bator supplement with 5% CO2. KSHV BAC36 was har-
vested as described previously (20). Brieﬂy, BCBL-1 cells
bearing with KSHV BAC36 were maintained in RPMI-
1640 supplemented with 10% fetal calf serum (FCS) and
150mg/ml hygromycin (Sigma-Aldrich, St. Louis, MO
USA). Recombinant Vero cells harboring JSC-1-derived
rKSHV.219 viruses, which express green ﬂuorescent
protein (GFP) during infection but red ﬂuorescent
protein during lytic cycle (21), were maintained in
Dulbecco’s Modiﬁed Eagle Medium (DMEM)
supplemented with 10% FCS and 5mg/ml puromycin
(Calbiochem, San Diego, CA, USA). KSHV BAC36 was
induced into the lytic cycle by adding 20ng/ml 12-O-
tetradecanoyl phorbol-13-acetate (TPA; Sigma-Aldrich,
St. Louis, MO, USA), and 1.25mM sodium butyrate and
culture continued for 5 days. rKSHV.219 was induced into
lytic cycle by infecting with the baculovirus harboring
KSHV/RTA (BacK50) and following by a treatment of
1.25mM sodium butyrate as described previously (21).
Culture supernatant was then ﬁltered through a 0.45mm
ﬁlter and concentrated by centrifugation at 18000g. Virus
titer was determined by infecting 293T cells with serially
diluted culture supernatant and counting the percentage of
GFP positive cells. For KSHV infection, a >10 MOI viral
concentrate was overlaid onto LECs and centrifuged at
3000g for 30min at room temperature to enhance the in-
fection rate. The cells were then incubated at 37 C for 2h
and washed with phosphate buffered saline (PBS) followed
byachangetofreshmedium. RNAwas harvestedtwodays
post-infection using a Qiagen
TM (Valencia, CA, USA)
RNeasy kit by following the manufacturer’s suggestions.
Microarray hybridization
Total RNA from KSHV infected LECs or mock infections
with biological replicates were checked for RNA integrity
by Bioanalyzer (Agilent, Santa Clara, CA, USA). Twomg
of total RNA served as the starting material and mRNA
was puriﬁed using a RiboMinus human transcriptome
isolation kit (Invitrogen, Carlsbad, CA, USA). cDNA
was then synthesized, labeled and fragmented using a
GeneChip WT cDNA synthesis kit and a WT terminal
labeling kit (Affymetrix, Santa Clara, CA, USA).
Hybridization and array scanning were carried out accord-
ing to the manufacturer’s instructions. The data has been
deposited in NCBI’s Gene Expression Omnibus (GEO)
database and has the accession number of GSE26341.
Additional microarray data
Raw CEL ﬁles of Affymetrix Human Exon 1.0 ST arrays
for CD34
+hematopoietic stem/precursor cells and periph-
eral blood mononuclear cells (PBMCs) were downloaded
from NCBI GEO website (series accession number
GSE15207). CEL ﬁles of Affymetrix Human Genome
U133 Plus 2.0 arrays for CD34
+ cells and PBMC were
from our previous publication (22), and KSHV-infected
LECs (KLECs) and uninfected LECs were from GEO
(series accession number GSE16354).
Gene expression analysis
For the gene expression analysis based on the Affymetrix
Human Genome U133 Plus 2.0 platform, we performed
RMA normalization and summarization using the ‘affy’
package in the Bioconductor suite as described previously
(13). We then identiﬁed differential gene expression
between KLEC and LEC by the ‘limma’ package and
calculated the positive false discovery rate (pFDR) by the
‘q-value’ package in the Bioconductor suite (13). Principal
components analysis (PCA) and multidimensional scaling
(MDS) plots were processed by the Partek Genomics Suite
6.5 (Partek, St. Louis, MO, USA).
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data, we used AltAnalyze (23) with Ensembl build 54,
human genome build 19 (GRCh37) and Affymetrix anno-
tation ﬁles. Analysis was carried out at the default settings.
Brieﬂy, RMA summarized probe set intensities and
DABG (‘detection above background’) P-values were
calculated using the Affymetrix Power Tools (APT),
which was automatically called from AltAnalyze. Probe
sets uniquely mapped to the each Ensembl gene accession
(ENSG) were considered constitutive and were used for
calculating gene expression values. For each ENSG, gene
expression was determined by the mean expression inten-
sities of all constitutive probe sets. The Bioconductor
R package ‘q-value’ was used to calculate pFDR from
the raw P-values for KLEC and LEC data. The
complete gene expression results are presented in File S1
in Supplementary Data.
Alternative splicing analysis
In order to identify alternative expressed exons, we used
both AltAnalyze and easyExon (24) to conduct the AS
analysis. Exon array raw data (CEL ﬁles) were normalized
and summarized using Affymetrix Power Tools (APT)
with the RMA-sketch algorithm. AltAnalyze was run
using the default parameters. The default signal ﬁltration
only retained probe sets with an intensity of more than
70 and a DABG P-value of smaller than 0.05. The same
database (Ensembl release 54) that had been used for gene
expression analysis was used for mapping the probe sets
to annotated exons. Splicing-index (SI) and MiDAS stat-
istical algorithms were used for AS identiﬁcation (24).
Probe sets with a MiDAS P-value smaller than 0.05
were considered signiﬁcant for exon inclusion/exclusion.
The complete AS analysis results are presented in File
S2 in Supplementary Data. The degree of AS was gener-
ally represented by normalized intensity (NI), which
means exon level intensity divided by gene level intensity.
NI, rather than probe set intensity, was used for plotting
exon level heat maps and PCA/MDS ﬁgures in order to
obtain a better representation of the AS degrees.
Alternative protein domains and microRNA binding sites
analysis
To identify protein domains and motifs potentially modi-
ﬁed by AS, a database containing aligning and non-
aligning proteins for all probe sets was built using
AltAnalyze. AltAnalyze aligns probe sets to protein do-
mains using ‘inferred comparison’ (default option) and
reports the domains to which the differentially expressed
probe sets align (23,25).
In addition to protein annotations, putative microRNA
binding sites predicted by PicTar (http://pictar.mdc-berlin
.de/), miRanda (26), miRbase (27) and TargetScan (http://
www.targetscan.org/) within probe selection region were
also pre-aligned and stored in an AltAnalyze database.
Differential expressed probe sets aligned to protein
domain or microRNA binding sites were subjected to
gene set enrichment analysis. Gene sets with three or
more associated genes, whose domains or motifs had
z scores>2, microRNA binding sites had z scores >2
and had a Benjamini-Hochberg P<0.05, were reported.
The AltAnalyze export ﬁle for graphic presentation
of domain architecture by Domaingraph is provided as
File S6 in Supplementary Data.
Gene ontology, pathway and network analysis
The ﬁltered AS genes were subjected to gene ontology
enrichment analysis using AltAnalyze bundled module
GO-Elite (http://www.genmapp.org/go_elite). GO-Elite
implementsanover-representationstatisticalinferencethat
can identify signiﬁcantly enriched gene ontology (GO)
categories with AS exons. GO terms with a z-score >2,
a permutation of P<0.01 and three or more regulated
genes for each GO term were reported as signiﬁcant.
Canonical pathway and gene interaction network analysis
were conducted with Ingenuity Pathway Analysis web tool
(http://www.ingenuity.com/).
Conﬁrmation of alternative spliced mRNA and differential
gene expression
To conﬁrm the AS events identiﬁed by the MiDAS algo-
rithm, we designed primer pairs ﬂanking the AS exon and
quantitatively analyzed the RT–PCR ampliﬁed fragments
produced by these primers. The forward primer sequence
for CLDND1 AS detection is 50-gctggcggagcaggaggat-30
and the reverse primer is 50-gtcctttctggtgggctataccaa-30.
One microgram total RNA was used as starting material
for the RT–PCR. The cDNA was synthesized by
Superscript III (Invitrogen Carlsbad, CA, USA) using ran-
dom hexamer. The subsequent PCR reaction was carried
out by GoTaq Master Mixes (Promega, Madison, WI,
USA) for 30 cycles at annealing temperature of 50 C.
The ampliﬁed DNA fragments were separated on an eth-
idium bromide stained agarose gel and quantiﬁed by
ImageQuant software (GE Healthcare, Piscataway, NJ,
USA). Quantitative PCR detection of AS and differential
gene expression was performed using Maxima SYBR
Green qPCR Master Mix (Fermentas, Gleen Burnie,
MD, USA) for 40 cycles at annealing temperature of
58 C with StepOne Plus Real-Time PCR system
(Applied Biosystems, Carlsbad, CA, USA). Primer se-
quences for qPCR detection of EGFR, CASP9,
BAIAP2L1, DVL2, RAPGEF5, MLPH and CTCL1 are
listed in Supplementary Table S1.
Knocking down RAPGEF5 by RNA interference
For the lentivirus-expressed shRNA against RAPGEF5
(NM_012294), two 21-nt sequences corresponding coding
sequences 1145–1165 (50-gctaagaagtatcaaggcaaa-30) and
1376–1396 (50-cgtcacactgtagatgaatat-30) inserted into
pLKO.1 were obtained from the National RNAi Core
Facility at Academia Sinica, Taiwan (http://rnai.genmed
.sinica.edu.tw/en/).
Transwell cell migration assay
Cell migration ability was evaluated using Costar
Transwell Polycarbonate Permeable Supports (Corning,
NY, USA). Brieﬂy, 5 10
4 cells in 400ml of culture
medium were overlaid on the upper chamber of the
6972 Nucleic Acids Research, 2011,Vol.39, No. 16Transwell device, while 600ml of medium supplemented
with 10ng/ml human VEGF (R&D Systems, Minneapolis,
MN, USA) was added to the lower chamber. The pore size
of the polycarbonate membrane situated between these
two chambers is 8mm. After 6h of 37 C incubation, the
membrane was ﬁxed in 4% paraformaldehyde for 20min
at room temperature and then stained with Hoechst 33342
solution (Sigma-Aldrich, St. Louis, MO, USA) for 30min.
Migrated cells on the bottom side of the membrane were
counted using a ﬂuorescent microscope.
RESULTS
Global identiﬁcation of alternative splicing events in
KSHV-infected LECs
To uncover the speciﬁc traits of the exome expression
induced by KSHV, we used the Affymetrix exon arrays
to determine the exon expression proﬁles of infected and
uninfected primary LEC. A BCBL-1 cell-derived recom-
binant KSHV that expresses green ﬂuorescent protein
(GFP) (20) was used to infect a pure population of
LEC. Uninfected LECs showed a characteristic contact-
inhibited cobble stone appearance, but the infected LECs
(KSHV-LECs) became elongated and spindle shaped
(Figure 1A). KSHV latent nuclear antigen (LANA) was
expressed in the infected cells and showed a typical nuclear
stippling staining pattern (Figure 1A, right panel). Total
RNA was collected 48h after KSHV infection. Pilot
quality control PCR test proved that the transcripts
of KSHV latent genes were present and intact in the
KSHV-LECs (Figure 1A). KSHV-LEC RNA was then
subjected to hybridization to Human Exon 1.0 ST
GeneChip arrays that consist of 5362207 different oligo-
nucleotides, corresponding to more than 1400000 probe
sets (PS). Exons or parts of exons within a gene are rep-
resented on the microarray by individual PS, and were
considered discrete units for our analysis of the transcript
isoform-processing differences. Of note, indirect paracrine
effects may also contribute in observed AS events as we
reached  80–90% infectivity but using the whole LEC
culture (composed of infected and uninfected cells) for
exon array analysis.
Initially, a global analysis was carried out at gene level
(i.e. individual transcript level) by summarizing all PS
signal values from a given Ensembl gene into one unique
value. A PCA based on genes differentially expressed
between sample groups (pFDR<0.1) showed that the
KSHV-infected LECs and parental LECs segregated in a
different spatial locations, substantiating that a very spe-
ciﬁc gene expression proﬁle was stimulated by KSHV in-
fection, as has been previously reported (13) (Figure 1B,
left panel).
At the exome level, probe select regions (PSRs,  exons)
were recognized as alternatively spliced exons using two
free open source applications: AltAnalyze (23) and
easyExon (24). Both applications utilize the MiDAS algo-
rithm, which calculates a splicing index (SI) ﬁrst and then
performs statistical inference on the SI to obtain a MiDAS
P-value. To identify alternative exons, AltAnalyze was
run using the default parameters. The CEL ﬁles of three
KSHV infected LECs (KLECs) and two mock infection
controls (LECs) were summarized by RMA and ﬁltered by
the SI and MiDAS statistical algorithms (P-value<0.05).
The corresponding genomic library ﬁles were based on
Ensembl Release 54 (GRCh37/hg19). Probe sets with
large cross-hybridization scores were removed to ensure
the ﬁdelity of the microarray results. To identify high-
conﬁdence alternative exons, only regulated probe sets
overlapping with exons in annotated mRNAs (i.e.
categorized as ‘core’ PSRs by Affymetrix) were used for
the further analyses. In the end, a total of 805 core PSRs
were obtained by ﬁltering and thus identiﬁed as differen-
tially expressed on KSHV infection (MiDAS P<0.05; see
File S2 in Supplementary Data). The PCA plot produced
using these normalized intensities of PSRs illustrates the
segregation of the infected and uninfected LEC at the
isoform levels (Figure 1B, right panel) and shows clearly
that the exome pattern in KSHV-infected LEC is also
quite different from that of uninfected cells.
AS is a key feature of KSHV infection
Having deﬁned the entire expression map of the human
exome in KSHV-LEC, we examined in depth the exons
and genes that might be involved in alternative splicing
events. The above core PSRs belong to 542 alternatively
spliced genes and the nature of the isoform changes at the
transcript level is illustrated in Figure 1C. These categories
were automatically classiﬁed on the basis of the positions
of the variable probe sets, followed by manual examin-
ation based on visualization of the entire transcript. A
signiﬁcant number (261/542, or 48.2%) of genes showed
very complex patterns of isoform variation that were dif-
ﬁcult to group (Figure 1C). Other transcript variations
(n=281) were identiﬁed at the level of transcript termin-
ation (29, or 10.3%), transcript initiation (72, or 25.6%)
and promoter alteration (41, or 14.6%) (Figure 1C; the-
oretical transcripts with distinct exon compositions are
also shown). The sum of the differential splicing isoforms
is more than that of the alternative spliced genes since
multiple alternative splicing events may occur in the
same gene. On average, there were 1.49 (805/542) alterna-
tively spliced exons per gene. Notably, some of the genes
that showed changes at the level of whole gene expres-
sion also showed further changes in terms of splicing, tran-
script termination and/or transcript initiation. Examples
of this include IL1B and EGFR (28) and suggest that
transcript isoform variation constitutes a large part of
the genetic variation we have observed in this study
and in previous gene level-based KSHV transcriptomic
studies (13).
The exon expression proﬁles of the above 542 genes are
presented in Figure 1D as a heat map. The top 50 most
signiﬁcant in terms of their MiDAS P-value alternative
spliced exons and their corresponding transcript names
are also listed (Figure 1D). GATA2, a key stemness
factor in CD133
+ endothelial stem cells, which plays a
critical role in vascular system development (29) is one
of them (Figure 1D). Overexpressing GATA2 in matured
endothelial cells induces dedifferentiation-like transcrip-
tome drift (22). Also present in this group are MAF and
Nucleic Acids Research, 2011,Vol.39, No. 16 6973AB
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Figure 1. KSHV induces alternative RNA splicing in infected LEC. (A) Conﬁrmation of KSHV infection in LECs. The cell morphology of mock
infection LECs at 2 days (LEC panel) shows a cobble stone appearance, whereas LECs infected by BCBL1-derived rKSHV at 2 days have become
elongated and spindle shaped (KLEC panels). The GFP positive cells indicate successful KSHV infection. KSHV infection was further conﬁrmed by
RT–PCR of KSHV genes (upper-right panel). LEC and KLEC indicate cDNA from these two samples was used as PCR-template. LEC- and
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(continued)IGFBP2, which are two oncofetal proteins that are essen-
tial for normal embryonic growth and development (30–
33). Various angiogenesis related genes, such as EPHB2,
HIF3A and RUNX1T1, were also found to be altered by
KSHV, which is consistent with the clinical observation
that KS is a highly angiogenic neoplasm (34). Exons of
various genes involved in cell growth regulation or DNA
repair, including BRCA1, EGFR and SMAD6, were also
in this group (Figure 1D). Among KSHV-regulated
isoforms, exons 4–8 of ST5 (Suppression of tumorigenicity
5) are down-regulated (Supplementary Figure S1). On the
other hand, exon 5 of CLDND1 (Cloudin N-terminal
domain 1) was found included in KSHV-infected LEC
whose AS pattern is a typical simple exon inclusion
(Figure 1D and E). As shown in Figure 1E, the AS of
CLDND1 was validated by RT–PCR using exon-body
primers present in the two exons ﬂanking the candidate
probe set.
Functional module and pathway analysis as a framework
for interpreting the biology of KSHV-induced AS
The exon/gene list gave us preliminary insights into the
functional consequences of the detected differential iso-
form expression. To understand more about how AS
might be correlated with sarcomagenesis and the KSHV
life cycle, as well as to provide quantitative evidence, the
542 spliced variants identiﬁed were subjected to a GO
database analysis by GO-Elite program implemented in
AltAnalyze (35). The aim was to pinpoint statistically
overrepresented functional groups within this AS list.
The GO categories of the biological processes that were
statistically overrepresented (P<0.05) among genes with
different exons are shown in Figure 2A. Genes regulating
the cell cycle, cell migration, cell adhesion and cell
junction assembly were signiﬁcantly affected by KSHV,
implying that KSHV is actively involved in the regulation
of LEC motility and proliferation, that is promoting
lymphangiogenesis. It has been shown that KSHV, as
well as viral proteins, are able to induce cell migration in
HUVECs and immortalized microvascular endothelial
cells (MVECs) (36–38). We conﬁrmed by Transwell
assay that KSHV also stimulates the motility of primary
LECs (Figure 2A, histogram).
The ‘insulin receptor’ and ‘smoothened signaling’
pathways were also both affected by KSHV (Figure 2A,
Supplementary Figure S2A). Insulin receptor (INSR) has
been shown to be essential for the virus-induced tumori-
genesis of Kaposi’s sarcoma (39). Further KSHV-
regulated canonical pathways were revealed when the
AS genes were subjected to analysis by the Ingenuity
Pathway Analysis (IPA) web tool. KSHV-induced AS
events were found to involve cancer pathways (such as the
HER-2/neu signaling pathway, Figure 2B, Supplementary
Figure S2B) and active cell cycle genes (such as the ‘G2/M
DNA Damage Checkpoint Regulation’ one; Figure 2B,
Supplementary Figure S2C). The top-ranked canonical
pathway is ‘Virus Entry via Endocytic Pathways’, especially
the ‘Macropinocytosis Signaling’ (Figure 2B, Supplementary
Figure S2D and S2E). It has been reported that KSHV
utilizes an actin polymerization-dependent macropinocytic
pathway to enter both HUVECs and dermal MVECs (28).
The results from the exon array analysis support the hypoth-
esis that KSHV applies a similar macropinocytic pathway
when entering primary LECs. Finally, a number of
pathways that have not been linked with KSHV infection,
such as the GNRH (gonadotrophin releasing hormone) and
RAR (retinoic acid receptor) pathways, were also pinpointed
(Figure 2B, Supplementary Figure S2F and S2G).
Genetic networks and submodules in KSHV-infected
LECs
Increasing evidence shows that genes do not act individu-
ally but collaborate in genetic networks. To better under-
stand how the AS genes that are enriched in KSHV-LECs
are related to each other, we performed genetic network
analysis. AS transcripts were inputted into the IPA
software package in order to construct network modules.
The knowledge base behind IPA summarizes the known
molecular interactions found in the published literature.
The term ‘network’ in IPA is not the same as a biological
or canonical pathway with a distinct function (i.e. angio-
genesis) but rather is a reﬂection of all the interactions of a
given protein as deﬁned in the literature.
Among KSHV-regulated RNA isoforms, a major net-
work consisting of 85 genes was identiﬁed (Figure 3 and
File S3 in Supplementary Data). This network includes
known angiogenesis or cell motility genes. Among these
Figure 1. Continued
KLEC- mean no-RT control, and the (–) set is a no template control. Three KSHV genes: LANA, vCyclin and vFLIP were all expressed in the
KLECs. Immunoﬂuorescent staining of KSHV LANA protein is demonstrated in the lower right panel, which shows a typical nuclear stippling
staining pattern. (B) PCA plots of both gene and exon levels between KLEC and LEC. The PCA plot, based on the differential expressed genes with
a pFDR<0.1 is shown (Left). (Right) A PCA plot of normalized intensities from probe sets with MiDAS P<0.05. KSHV-LEC samples are labeled
in red while LEC samples are labeled in blue. (C) Statistics of AS events. AS events detected by AltAnalyze are summarized into the categories
indicated. (D) A heat map of AS probe sets. The color of heat map is labeled according to the NI of each probe set. In red, inclusive exons; in blue,
exclusive. The affected AS genes are also listed. (E) Veriﬁcation of CLDND1 AS event. (Upper-left) The DomainGraph output for domain anno-
tation. The top row labels the protein coding sequence (CDS), and the blue box indicates the Cloudin domain. The middle row shows the com-
position of mRNA. Each exon is labeled with a number. The lower row designates the exon array probe select regions (PSRs). Probe sets upregulated
in KLECs are in red. Blue lines below the last two PSRs indicate that these regions contain microRNA binding sites. The red rectangle emphasizes
that exon 5 is upregulated in KLECs. (Lower-left) The analysis results from easyExon. The upper polygonal graph demonstrates the log2-scaled
intensities across the whole transcript cluster (red: KLEC; blue: LEC). The SI and FC plots indicate the splicing index and fold-change across each
probe set, respectively. The red box again highlights a differential expressed probe set. (Upper-right) PCR conﬁrmation on AS events. A primer pair
designed based on exon 1 and 6 ampliﬁes two fragments that are different in size. The larger form is enriched in KLECs, which is consistent with the
array data. (Lower-right) A histogram of the quantiﬁed long form/short form ratio. The Student’s t-test indicates the ratio is different between
KLECs and LECs (P<0.0001).
Nucleic Acids Research, 2011,Vol.39, No. 16 6975Figure 2. Functional analysis of KSHV induced AS genes. (A) Gene ontology (GO) tree of KSHV induced AS genes in LECs. AS No.: AS gene
number. %: percentage of AS genes in this GO category. P-value: GO-Elite calculated P-value. The subﬁgure demonstrates the difference in
migration rate of LECs upon KSHV infection. *P<0.05 (B) Ingenuity canonical pathway analysis of AS genes. The P-values were calculated by
the Fisher’s exact test. Central line: the P-value threshold (0.05). Connected grey dots: changed gene ratio in each canonical pathway.
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ase receptor), ITGB4, CD83 and CDH2 (N-cadherin) are
able to induce cell migration and/or invasion, which may
in turn contribute to KSHV-induced LEC migration/
invasion (highlighted in the ‘motility module’, Figure 3).
Other genes in this main network have no previous known
involvement with KSHV biology, but known to be asso-
ciated with angiogenesis; these include DLG1, IL1B,
XDH (xanthine dehydrogenase), NFATC4, FHL1 (four
and a half LIM domains 1) and ADRB1 (adrenergic,
b-1, receptor). Of these genes, DLG1 (hDLG, human
homologue of the Drosophila discs large gene) contrib-
utes to tumor angiogenesis and neoangiogenesis via scaf-
folding G-protein-coupled receptors (GPCRs) such as
tumor endothelial marker 5 (TEM5) and other TEM5-
like proteins at the plasma membrane (40). Similarly,
NFATC4 signaling is able to initiate cross-talk between
blood vessels and the surrounding tissues, which helps
to pattern the vasculature (41). FHL1 has been found
to be up-regulated in the pulmonary vasculature of pul-
monary hypertension patients (42). The KSHV-induced
angiogenic AS transcripts mentioned above form a
sub-module in the main network (the ‘EC module’,
Figure 3), with IL1B being the hub gene (genes with higher
connectivity to others or resided in a position among
submodules in the major network). This network structure
suggests that the pro-inﬂammatory cytokine IL1B plays a
critical role in KSHV-related lymphangiogenesis and
sarcomagenesis.
Hub genes in a biological system very often play more
important roles than spoke genes, and the dysregulation
of a hub can eventually lead to disruption of the genetic
network and the malfunction of the cell (43). Systems
biology analysis also revealed other KSHV-regulated
hub genes. These included ADRB1, FOXC2, DLG1,
DNM1 (DNA (cytosine-5-)-methyltransferase 1), PLCB1
and INSR (Figure 3). FOXC2 is one of the downstream
regulators of the canonical Wnt signaling pathway. FZD1
(receptor for Wnt proteins) and TBX1, a downstream
effector of the Wnt-b-catenin signaling pathway (44),
were also included in KSHV-LECs (Figure 3). The genes
involved in the INSR pathway, as revealed by GO analysis
Figure 3. A genetic network containing products of KSHV-induced AS genes. Protein nodes with AS are indicated by a red color. Solid lines
designate binding and interaction, and dashed lines designate an indirect interaction. Proteins involved in cell motility are highlighted by a solid blue
circle. The green-dashed elliptical region contains genes involved in endothelial cell activities (EC module), while the blue-dashed region represents
the Wnt-b-catenin module. Genes mentioned in the main text are in red, and those in purple belong to the INSR pathway. The gene function of each
node is denoted in different shapes.
Nucleic Acids Research, 2011,Vol.39, No. 16 6977in Figure 2A, were all included and form an important
part of the main network (in purple, Figure 3).
Dedifferentiation-like AS drift in KSHV-infected LEC
From the present study, it can be clearly seen that KSHV
is able to inﬂuence the splicing patterns of critical stemness
genes and oncofetal proteins [such as GATA2 (22) and
NFATC4 (41)] in LECs. The splicing pattern of
the CD34 precursor marker was also altered by KSHV
(File S2 in Supplementary Data). Since re-expression
of GATA2 stemness genes is able to induce reprogram-
ming and dedifferentiation of matured endothelial cells
(45), and it has been recognized that aggressive and poor
prognostic tumors acquire characters reminiscent of
embryonic stem cells (ESCs) (46), we hypothesized that
KSHV infection may induce dedifferentiation-like tran-
scriptome reprogramming of mature LECs. When pub-
lished mRNA expression arrays (14,22) were used to
examine our hypothesis, no dedifferentiation could be
found (Figure 4A). However, when transcriptome repro-
gramming was examined on an exome level, MDS analysis
clearly showed that the exomes of the infected LECs had
moved away from the parental pattern toward a pattern
closer to that of CD34
+ endothelial stem/precursor cells
(Figure 4B, left panel). This change was quantiﬁed by
measuring the average linkage Euclidean distances
between sample groups and KSHV-LECs were found to
be closer to CD34
+ precursor cells than to uninfected
LECs (Figure 4B, right panel).
A total of 14 AS transcripts with an exon-exclusion
pattern, as well as another 19 exon-inclusion patterns,
were found to be common between KSHV-infected
LECs and CD34
+ cells (Figure 4C). CD34
+ exons, such
as those in EGFR, CCDC85A, INCENP, ITGB4,
KCNMB4, LIMK2, LTBP4, LY75, MLPH, RGS3,
TPM1 and TXNRD2, were included more often in
KSHV-LECs. In contrast, exons in CD55 and CD83 etc.
were excluded (Figure 4D). In addition, EGFR and
CASP9 were also in common between CD34
+ precursor
cells and KSHV-LECs (Figure 4E). Both AS events include
an additional exon into their spliced RNA isoforms in
regions encoding important protein domains (red circles,
Figure 4E), which suggest an alternation in the protein’s
activity or a change in the protein’s regulatory mechanism.
To support the reproducibility of our work, we used
another rKSHV.219 viruses derived from JSC-1 cells
(21) for RT–qPCR validation. The AS of EGFR and
CASP9 could be validated by RT–qPCR using primer
sets speciﬁc for exons 25 or 26 of EGFR, as well as
primers for exons 4b or 5 of CASP9. The expression
ratios between altered and constant exons were compared
(Figure 4E). The consistency between exon array and
RT–qPCR data suggests the reliability of our results.
Modiﬁcation of domain and motif composition by
KSHV-induced isoforms
It is well known that splicing not only provides feedback
that affects transcription, but also it can feed forward by
modulating protein function. The above EGFR and
CASP9 isoforms analysis suggested that it would be
useful to explore protein domains and motifs globally
for possibly modiﬁcation/disruption in KSHV-LECs.
AltAnalyze, which contains a database consisting of pro-
tein domain and motif information obtained from multiple
protein annotation databases (UniProt, InterPro) (25),
was used for this task. A domain database search revealed
1394 protein domains in 36.2% (196/542) of genes that
have alternatively spliced exons. Of these, 17 domain/
motif types affected by KSHV were involved in adhesion
and oncogenic signal transduction. These included SH3,
ﬁbronectin, collagen, Ras GEF, RasGRF and pleckstrin/
G-protein interact domains (Figure 5A, File S4
Supplementary Data). Several AS isoforms, such as
BAIAP2L1 (BAI1-associated protein 2-like 1, involved
in the formation of clusters of actin bundles) and DVL2
(dishevelled, dsh homolog 2; a component of the Wnt sig-
naling pathway), have alternations in SH3 and DEP
protein domains, respectively (Figure 5B). The AS of
both transcripts was validated by RT–qPCR in
rKSHV.219 viruses infected LECs using primer sets specif-
ic for exons 11 and 12 of BAIAP2L1, or for exons 12, 13
of DVL2. The expression ratios between altered and con-
stant exons were compared (Figure 5B). The tendencies of
exon inclusion/exclusion of these two genes were similar
between exon array and qRT–PCR results.
AS modiﬁes microRNA binding site architecture
Another consequence of alternative RNA splicing is the
gain or loss of microRNA binding sites in the AS
isoforms. We next explored the possibility that KSHV-
induced AS may cause the expressed isoforms to escape
from or be newly included in microRNA-mediated regu-
lation. We ﬁrst determined which microRNAs (miRNAs)
are present in KSHV-LEC. The overall miRNA expres-
sion signals in KSHV-LEC was determined by the Agilent
v2 miRNA array, and a miRNA was assigned as ‘Present’
if its hybridization intensity was by a factor >16 (2
4). This
cutoff value was determined by taking advantage of the
fact that there are also probes detecting KSHV and EBV
viral miRNAs on the Agilent miRNA chips. For most
KSHV viral miRNAs, but not the EBV ones, their nor-
malized array signals were more than 2
4 (Supplementary
Figure S3). Using this criterion we found there were 216
cellular miRNAs expressed in KSHV-LECs and the top 40
miRNAs are shown (Figure 6A, File S5 Supplementary
Data). The most abundant miRNA is miR-21, which
can be induced by the KSHV K15 protein, a viral angio-
genic latent protein (47). Another abundant KSHV-
induced miRNA is miR-221, which is an anti-angiogenic
miRNA present in KS tissues (48,49) (Figure 6A).
We then again applied AltAnalyze, which also contains
detailed information on miRNA binding sites as predicted
by multiple algorithms (PicTar, miRbase, miRanda and
TargetScan) (25). Overall, 7.45% (60/805) of KSHV-
induced AS events were found to harbor a predicted
gain/loss of at least one miRNA binding site (Figure 6B).
Taking into account whether miRNAs exist in KEHV-
LECs or not, 85/302 (28.15%) miRNA binding motifs
would seem to be signiﬁcantly altered in KSHV-LECs
(Figure 6B).




Figure 4. Dedifferentiation-like AS drift in KSHV-infected LECs. (A) A gene-level MDS plot using KLEC-LEC differential expressed genes
(Affymetrix Human Genome U133 Plus 2.0 array). In this ﬁgure, no dedifferentiation could be found. (B) An exon-level MDS plot using NI of
KSHV-induced AS probe sets. An arrow indicates that the exomes of the infected LECs have moved away from those of control LECs and toward
to those of CD34
+ endothelial stem/precursor cells. (right) Average linkage distances between sample groups. (C) Venn diagrams showing AS events
common between KSHV-LEC and CD34
+ cells. (D) A heat map showing the 33 AS events common between KSHV-LEC and CD34
+ cells. The
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(continued)The third parameter applied was the correlation of the
expression levels of the candidate mRNA-miRNA pairs in
LECs and KSHV-LECs. It has been reported that the
expression levels of a miRNA and its downstream
mRNA targets are negatively correlated (50). So, when
AS events with inclusive miRNA sites were checked, it
was found that the levels were down in KSHV-LECs
compared with those in parental LECs control. A total
of 16 genes passed this third criterion (Figure 6C, upper
panel). ATM, HOXA3 and AURKA were three typical
genes (Supplementary Figure S1). Another four genes,
IL4L, HSD17B7P2, RAPGEF5 and RGS3, with exon in-
clusion were up in KSHV-LEC (Figure 6C, lower panel).
Some miRNAs targeted more than one AS event in
KSHV-LECs and may therefore be more crucial.
miR-23a and miR-27a binding sites were over-represented
among KSHV-regulated AS events and both miRNA ex-
pression levels were on the top 10 in KSHV-infected LECs
(Figure 6A and C). Neither miRNA has been previously
associated with the KSHV life cycle or KS tumorigenesis.
The decreasing expression of MLPH and CTCL1 (both
with inclusive miRNA binding sites) in rKSHV.219
viruses infected LEC was veriﬁed by RT–qPCR, while
that of RAPGEF5 (with exclusive miRNA binding sites)
was increased (Figure 6D). The role of RAPGEF5 in
KSHV-induced pathogenicity was explored by examining
its function in LEC motility: when the expression of en-
dogenous RAPGEF5 was knocked down by shRNA, a
reduced cellular motility was observed (Figure 6E), sug-
gesting RAPGEF5 is crucial for LEC motility.
DISCUSSION
In this study, we did exon level expression proﬁling on
KSHV(+) LECs. Understanding the added complexity
of transcript-processing variations and the potential
outcome of these differences will greatly enhance our
knowledge of KS pathogenesis and KSHV life cycle.
Very few studies have investigated splicing regulation in
endothelial cells. Elucidating the underlying mechanisms
associated with KSHV-induced phenomena, such as LEC
motility, is critical to a better understanding of vascular
biology under normal and pathological conditions.
In this study we applied only the ‘Core’ exon panel from
the Affymetrix annotation. Since the exons in the ‘Core’
annotation set are well recognized ones, our results are
therefore reliable but are somewhat reliant on prior know-
ledge. It should be possible to identify more AS events and
get broader insights into KSHV and LECs biology if the
‘Extended’ or even the ‘Full’ exon panels are used. In
addition, it ought to be possible to ﬁnd novel KSHV-
regulated exons and RNA isoforms if we extend our
analysis further. On the other hand, the RNA-Seq appli-
cation in relation to next-generation sequencing (NGS)
can also be used to discover novel exons and RNA
isoforms [reviewed by (51)]; in these circumstances even,
more KSHV-regulated AS events should be found when
RNA-Seq is applied to the study of KSHV and KS
biology. A very recent article used whole-exome
sequencing to decipher the genetic basis of fatal classic
Kaposi sarcoma and discovered a homozygous splice-site
mutation in the STIM1 gene (52). This proof-of-principle
similar case to KS also supports the critical role of AS in
KS tumorigenesis.
The AS induced by KSHV infection may either be
caused speciﬁcally by KSHV or by general virus-host
interaction. To clarify these issues, we analyzed another
exon array dataset regarding EBV-infected primary B cells
(GEO dataset GSE20200). In this analysis, 773 genes
harbored alternative splicing upon early EBV infection,
in which 49 AS events were also found in
KSHV-infected LEC (Supplementary Figure S4 and
Supplementary Table S2). These 49 AS events represent
the common AS patterns that can be induced by the in-
fection of g-herpesvirus.
Gene expression proﬁles for KSHV-infected cells have
been reported by a few groups (13,53,54). Nevertheless,
assigning biological signiﬁcance and identifying potential
targets is always a daunting task. Analyzing gene signa-
tures using systems biology approaches, such as dividing
the genes into functional subgroups or network modules,
is an efﬁcient way of obtaining more insights from the
gene lists (55). A systemic strategy is mandatory when
trying to view the overall molecular events as the biologic-
al system for a given biological process; this allows im-
portant genes to be pinpointed as controllers (55). Those
key genes often serve as hubs that maintain the stability of
the genetic module or act as go-between connecting
modules within a major network. By applying systems
biology tools we were able to identify a major functional
network that consisted of KSHV-infected AS events. Hub
genes, such as IL1B, FOXC2 and INSR, were then
identiﬁed using this systemic approach. It should be
noted, however, because we applied a knowledge-based
strategy to construct the genetic networks and to
separate the various functional groups, only genes with
known interactions are included. In such circumstances,
the enrichment of AS events and/or the appearance of
hubs may be a consequence of previous intense research
in these areas. There are probably many more potential
key genes currently without known interactions that are
still waited to be unveiled.
Six insulin receptor (INSR) pathway genes (IL1B,
INSR, IRS2, FOXC2, PRKCA and SOCS7) were found
Figure 4. Continued
Gene symbols of AS genes are also listed. (E) DomainGraph ‘Probeset view’ of EGFR and CASP9. EGFR exon 25 is downregulated upon KSHV
infection, and this KSHV-regulated isoform would seem to harbor an altered protein kinase domain. Part of CASP9 exon 4 is downregulated in
infected LECs, and this AS will affect the integrity and function of the CARD domain. Green boxes: probe sets with exon exclusion; White boxes:
probe sets that do not meet the minimum expression threshold in AltAnalyze; Gray boxes: no alternative expression event detected. (right) Validation
of AS events by RT–qPCR. Primer sets for EGFR exon 25 and CASP9 exon 4b were designed for detecting differential expressed exons, whereas
primer sets for EGFR exon 26 and CASP9 exon 5 for constantly expressed exons. Total RNA was from primary LECs infected with JSC-1-derived
rKSHV.219 viruses. Results are expressed as the mean±SD. Ratios between AS exons and constant exons are shown. *P<0.05 by Student’s t-test.
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(Figure 3). Systems biology analysis further revealed that
INSR is a hub gene in this KSHV-regulated genetic
network (Figure 3). This further suggests a critical role
for this pathway in KS tumorigenesis and the KSHV life
cycle. IL1B expression is detrimental to viral infection
(56). It has recently been shown that KSHV lytic gene
Orf63 is a viral homolog of NLR (nucleotide binding
and oligomerization, leucine-rich repeat) and can subvert
the function of cellular NLRs (57). As a result, KSHV
Orf63 hinders inﬂammasome formation and IL1B and
IL18 secretion during KSHV lytic replication (57). IL1B
and NLR-mediated innate immunity is suggested to be
important for the lifelong persistence of herpesviruses.
Our data weight the importance of IL1B in KSHV life
cycle and imply possible applications.
The exact biological roles of KSHV-induced protein
isoforms still need more investigation. We showed by
Figure 5. Modiﬁcation of domain and motif compositions within KSHV-induced isoforms. (A) Table of protein domains in genes with AS exons. In
total, 17 domains/motifs that are involved in adhesion and oncogenic signaling transduction are affected on KSHV infection. (B) Part of the SH3_2
domain is altered in BAIAP2L1 due to the upregulated exon 11. Similarly, part of the DEP domain (Domain found in Dishevelled, Egl-10, and
Pleckstrin) in DVL2 is affected on KSHV infection due to the downregulation of exon 12. Probe sets with exon inclusion are in red, whereas those
with exon exclusion in green. (right) Validation of AS events by RT–qPCR. Total RNA was from LECs infected with JSC-1-derived rKSHV.




Figure 6. AS modiﬁes miRNA binding site architecture. (A) The miRNA expression proﬁle of KSHV infected LECs. In total, 216 miRNAs that
have summarized probe set intensities >4 on a log2 scale can be considered to be expressed in the cells. The y-axis scale is the RMA-normalized
hybridization signal (log2 transformed) (B) Venn diagram of expressed miRNAs and altered miRNA binding sites identiﬁed by AltAnalyze. Overall,
85 miRNA-altered miRNA binding sites can be identiﬁed. (C) Correlation between differential gene expression and miRNA–miRNA binding sites
regulation. (Upper) Genes downregulated in KSHV-LEC, and their miRNA binding sites are in inclusive exons. (Lower) Genes up-regulated in
KSHV-LEC, and their miRNA binding sites are in exclusive exons. (Some ‘miR-’ preﬁxes were omitted for better demonstration.) (D) Relative
expression levels of genes with miRNA binding site alteration. Potential miRNA binding sites are upregulated in MLPH and CTCL1, and their gene
expression levels are signiﬁcantly down. In contrast, the miRNA binding sites in RAPGEF5 are downregulated, and its gene expression level is up.
Total RNA was from LECs infected with JSC-1-derived rKSHV. (E) RAPGEF5 is crucial for LEC motility. Primary LECs transduced with shRNA
against LacZ or RAPGEF5 were subjected to Transwell cell migration assays (right). The knock-down effect was measured by RT–qPCR (left).
Mean expression levels of RAPGEF5 were compared with that of GAPDH control.
6982 Nucleic Acids Research, 2011,Vol.39, No. 16RT–qPCR and Transwell assays that the expression of
RAPGEF5 (with exclusive miRNA binding sites) is in-
creased in KSHV-LEC, and this gene is crucial in LEC
motility (Figure 6E). KSHV may exploit RAPGEF5
splicing for enhancing the migration and spreading of
infected cells. Another AS product is CASP9 isoform (with
reduced exon 4 and defected CARD domain; Figure 4E).
The product from KSHV-induced AS CASP9 is expected
to be similar to that encoded by Casp9b, which is due to
the exclusion of an exons 3–6 cassette (58). Casp9b protein
acts as an endogenous inhibitor of Casp9a (with intact
CARD) by competing with the full-length Casp9a for
binding to the apoptosome (58–60). Casp9b protein also
directly interacts with Casp9a (full-length) for blocking
the autoproteolysis of the enzyme (59). We anticipate
that KSHV-induced AS CASP9 may also inhibit
wild-type CASP9 for KSHV to escape from apoptosis.
It is known that KSHV is able to induce ‘trans-
differentiation’-like transcriptome drift and this will inﬂu-
ence the cellular identity of infected ECs, thereby
contributing to KSHV-induced oncogenesis (13). On the
other hand, the possibility that KSHV may induce dedif-
ferentiation in infected cells has not been explored. It has
been recognized that during malignant transformation,
cancer cells acquire genetic mutations that override the
normal mechanisms that control cellular proliferation.
Cancer cells further acquire characters reminiscent of
normal stem cells during disease progression, and clinic-
ally cancer cells with poor differentiated pathological
grading usually have a worse therapeutic response
than those with well-differentiated morphology (61). The
degree of embryonic gene re-expression correlates with
pivotal tumor features and patient prognosis (62,63). In
poorly differentiated tumors, stem cell-like gene expres-
sion signatures are exhibited and the degree of stem cell
program recapitulation correlates with tumor stages and
patient survival (46,64). Identifying genes shared between
transformed cells, especially the more malignant ones, and
stem cells will help to unmask the pathogenic mechan-
isms at work in tumors, as well as provide us with novel
therapeutic targets and prognosis biomarkers. In this
study, it has been revealed by exon array that KSHV
can also induce ‘dedifferentiation’ like exome drift, which
is also readily disclosed by classical gene expression-based
transcriptome analysis (Figure 4). It has been shown
recently that KSHV is able to induce the expression of
an endothelial precursor cell marker (CD133) and various
mural cell markers (calponin, desmin and smooth muscle
alpha actin) (65), which support both dedifferentiation
and trans-differentiation may occur in KSHV-infected
cells.
In summary, our present results demonstrate that the
nature of KSHV-induced transcriptome changes is not
only quantitative but is also qualitatively. AS is a key
component of cellular reprogramming upon viral infec-
tion, and exon array analysis could identify previously
undisclosed potential oncogenic pathways in an unbiased
manner. Our results imply that detecting exon changes is a
more sensitive tactic than analyzing mRNA levels only.
Careful studies of the functional variants arising from
AS in the context of in vitro and in vivo models of
oncogenesis are still necessary to further support the
clinical relevance of these exciting ﬁndings.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors acknowledge the technical services provided
by Microarray & Gene Expression Analysis Core Facility,
which was supported by National Research Program for
Genomic Medicine, National Science Council (NSC), of
the National Yang-Ming University VGH Genome
Research Center and the shRNA knockdown plasmids
provided by National RNAi Core Facility, Taiwan.
FUNDING
This work was supported by National Health Research
Institutes, Taiwan (NHRI-EX99-9704BI), National
Science Council, Taiwan (NSC98-3111-B-010-004,
NSC98-2320-B-010-020-MY3, NSC 99-2911-I-009-101
and NSC99-2627-B-010-010), Department of Health,
Taiwan (CCMP99-RD-063), Taipei Veteran General
Hospital (V100E2-011 and DOH100-TD-C-111-007,
Center of Excellence for Cancer Research at Taipei
Veterans General Hospital) and National Yang-Ming
University, Taiwan (Ministry of Education, Aim for the
Top University Plan). Funding for open access charge:
National Yang-Ming University, Taiwan (Ministry of
Education, Aim for the Top University Plan).
Conﬂict of interest statement. None declared.
REFERENCES
1. Black,D.L. (2000) Protein diversity from alternative splicing: a
challenge for bioinformatics and post-genome biology. Cell, 103,
367–370.
2. Clark,T.A., Sugnet,C.W. and Ares,M. Jr. (2002) Genomewide
analysis of mRNA processing in yeast using splicing-speciﬁc
microarrays. Science, 296, 907–910.
3. Johnson,J.M., Castle,J., Garrett-Engele,P., Kan,Z., Loerch,P.M.,
Armour,C.D., Santos,R., Schadt,E.E., Stoughton,R. and
Shoemaker,D.D. (2003) Genome-wide survey of human
alternative pre-mRNA splicing with exon junction microarrays.
Science, 302, 2141–2144.
4. Le,K., Mitsouras,K., Roy,M., Wang,Q., Xu,Q., Nelson,S.F. and
Lee,C. (2004) Detecting tissue-speciﬁc regulation of alternative
splicing as a qualitative change in microarray data.
Nucleic Acids Res., 32, e180.
5. Pan,Q., Shai,O., Misquitta,C., Zhang,W., Saltzman,A.L.,
Mohammad,N., Babak,T., Siu,H., Hughes,T.R., Morris,Q.D.
et al. (2004) Revealing global regulatory features of mammalian
alternative splicing using a quantitative microarray platform.
Mol. Cell, 16, 929–941.
6. Ule,J., Stefani,G., Mele,A., Ruggiu,M., Wang,X., Taneri,B.,
Gaasterland,T., Blencowe,B.J. and Darnell,R.B. (2006) An RNA
map predicting Nova-dependent splicing regulation. Nature, 444,
580–586.
7. Ule,J., Ule,A., Spencer,J., Williams,A., Hu,J.S., Cline,M.,
Wang,H., Clark,T., Fraser,C., Ruggiu,M. et al. (2005)
Nova regulates brain-speciﬁc splicing to shape the synapse.
Nat. Genet., 37, 844–852.
Nucleic Acids Research, 2011,Vol.39, No. 16 69838. Hengge,U.R., Ruzicka,T., Tyring,S.K., Stuschke,M.,
Roggendorf,M., Schwartz,R.A. and Seeber,S. (2002) Update
on Kaposi’s sarcoma and other HHV8 associated diseases.
Part 2: pathogenesis, Castleman’s disease, and pleural effusion
lymphoma. Lancet Infect Dis., 2, 344–352.
9. Chang,Y., Cesarman,E., Pessin,M.S., Lee,F., Culpepper,J.,
Knowles,D.M. and Moore,P.S. (1994) Identiﬁcation of
herpesvirus-like DNA sequences in AIDS-associated Kaposi’s
sarcoma. Science, 266, 1865–1869.
10. Ganem,D. (2010) KSHV and the pathogenesis of Kaposi
sarcoma: listening to human biology and medicine.
J. Clin. Invest., 120, 939–949.
11. Luan,S.L., Boulanger,E., Ye,H., Chanudet,E., Johnson,N.,
Hamoudi,R.A., Bacon,C.M., Liu,H., Huang,Y., Said,J. et al.
(2010) Primary effusion lymphoma: genomic proﬁling revealed
ampliﬁcation of SELPLG and CORO1C encoding for proteins
important for cell migration. J. Pathol., 222, 166–179.
12. Toth,Z., Maglinte,D.T., Lee,S.H., Lee,H.R., Wong,L.Y.,
Brulois,K.F., Lee,S., Buckley,J.D., Laird,P.W., Marquez,V.E.
et al. (2010) Epigenetic analysis of KSHV latent and lytic
genomes. PLoS Pathog., 6, e1001013.
13. Wang,H.W., Trotter,M.W., Lagos,D., Bourboulia,D.,
Henderson,S., Makinen,T., Elliman,S., Flanagan,A.M., Alitalo,K.
and Boshoff,C. (2004) Kaposi sarcoma herpesvirus-induced
cellular reprogramming contributes to the lymphatic endothelial
gene expression in Kaposi sarcoma. Nat. Genet., 36, 687–693.
14. Lagos,D., Trotter,M.W., Vart,R.J., Wang,H.W., Matthews,N.C.,
Hansen,A., Flore,O., Gotch,F. and Boshoff,C. (2007) Kaposi
sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen
presentation in lymphatic endothelial cells. Blood, 109, 1550–1558.
15. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer.
Cell, 100, 57–70.
16. Chang,W.Y. and Stanford,W.L. (2008) Translational control: a
new dimension in embryonic stem cell network analysis. Cell
Stem Cell, 2, 410–412.
17. Stites,E.C., Trampont,P.C., Ma,Z. and Ravichandran,K.S. (2007)
Network analysis of oncogenic Ras activation in cancer. Science,
318, 463–467.
18. Gardina,P.J., Clark,T.A., Shimada,B., Staples,M.K., Yang,Q.,
Veitch,J., Schweitzer,A., Awad,T., Sugnet,C., Dee,S. et al. (2006)
Alternative splicing and differential gene expression in colon
cancer detected by a whole genome exon array. BMC Genomics,
7, 325.
19. Clark,T.A., Schweitzer,A.C., Chen,T.X., Staples,M.K., Lu,G.,
Wang,H., Williams,A. and Blume,J.E. (2007) Discovery of
tissue-speciﬁc exons using comprehensive human exon
microarrays. Genome Biol., 8, R64.
20. Zhou,F.C., Zhang,Y.J., Deng,J.H., Wang,X.P., Pan,H.Y.,
Hettler,E. and Gao,S.J. (2002) Efﬁcient infection by a
recombinant Kaposi’s sarcoma-associated herpesvirus cloned in a
bacterial artiﬁcial chromosome: application for genetic analysis.
J. Virol., 76, 6185–6196.
21. Vieira,J. and O’Hearn,P.M. (2004) Use of the red ﬂuorescent
protein as a marker of Kaposi’s sarcoma-associated herpesvirus
lytic gene expression. Virology, 325, 225–240.
22. Huang,T.S., Hsieh,J.Y., Wu,Y.H., Jen,C.H., Tsuang,Y.H.,
Chiou,S.H., Partanen,J., Anderson,H., Jaatinen,T., Yu,Y.H. et al.
(2008) Functional network reconstruction reveals somatic
stemness genetic maps and dedifferentiation-like transcriptome
reprogramming induced by GATA2. Stem Cells, 26, 1186–1201.
23. Emig,D., Salomonis,N., Baumbach,J., Lengauer,T., Conklin,B.R.
and Albrecht,M. (2010) AltAnalyze and DomainGraph: analyzing
and visualizing exon expression data. Nucleic Acids Res.,
38(Suppl.), W755–W762.
24. Chang,T.Y., Li,Y.Y., Jen,C.H., Yang,T.P., Lin,C.H., Hsu,M.T.
and Wang,H.W. (2008) easyExon–a Java-based GUI tool for
processing and visualization of Affymetrix exon array data.
BMC Bioinformatics, 9, 432.
25. Salomonis,N., Nelson,B., Vranizan,K., Pico,A.R., Hanspers,K.,
Kuchinsky,A., Ta,L., Mercola,M. and Conklin,B.R. (2009)
Alternative splicing in the differentiation of human embryonic
stem cells into cardiac precursors. PLoS Comput. Biol., 5,
e1000553.
26. John,B., Enright,A.J., Aravin,A., Tuschl,T., Sander,C. and
Marks,D.S. (2004) Human MicroRNA targets. PLoS Biol., 2,
e363.
27. Grifﬁths-Jones,S., Saini,H.K., van Dongen,S. and Enright,A.J.
(2008) miRBase: tools for microRNA genomics.
Nucleic Acids Res., 36, D154–D158.
28. Raghu,H., Sharma-Walia,N., Veettil,M.V., Sadagopan,S. and
Chandran,B. (2009) Kaposi’s sarcoma-associated herpesvirus
utilizes an actin polymerization-dependent macropinocytic
pathway to enter human dermal microvascular endothelial and
human umbilical vein endothelial cells. J. Virol., 83, 4895–4911.
29. Bresnick,E.H., Lee,H.Y., Fujiwara,T., Johnson,K.D. and Keles,S.
(2010) GATA switches as developmental drivers. J. Biol. Chem.,
285, 31087–31093.
30. Busund,L.T., Richardsen,E., Busund,R., Ukkonen,T., Bjornsen,T.,
Busch,C. and Stalsberg,H. (2005) Signiﬁcant expression of
IGFBP2 in breast cancer compared with benign lesions.
J. Clin. Pathol., 58, 361–366.
31. Pouponnot,C., Sii-Felice,K., Hmitou,I., Rocques,N., Lecoin,L.,
Druillennec,S., Felder-Schmittbuhl,M.P. and Eychene,A. (2006)
Cell context reveals a dual role for Maf in oncogenesis.
Oncogene, 25, 1299–1310.
32. Zhang,W. and Fuller,G. (2007) IGFBP2 as a brain tumor
oncogene. Cancer Biol. Ther., 6, 995–996.
33. Zhang,C.C., Kaba,M., Iizuka,S., Huynh,H. and Lodish,H.F.
(2008) Angiopoietin-like 5 and IGFBP2 stimulate ex vivo
expansion of human cord blood hematopoietic stem cells as
assayed by NOD/SCID transplantation. Blood, 111, 3415–3423.
34. Boshoff,C. (1998) Kaposi’s sarcoma. Coupling herpesvirus to
angiogenesis. Nature, 391, 24–25.
35. Krishnan,K., Salomonis,N. and Guo,S. (2008) Identiﬁcation of
Spt5 target genes in zebraﬁsh development reveals its dual activity
in vivo. PLoS One, 3, e3621.
36. Bais,C., Van Geelen,A., Eroles,P., Mutlu,A., Chiozzini,C.,
Dias,S., Silverstein,R.L., Raﬁi,S. and Mesri,E.A. (2003) Kaposi’s
sarcoma associated herpesvirus G protein-coupled receptor
immortalizes human endothelial cells by activation of the VEGF
receptor-2/ KDR. Cancer Cell, 3, 131–143.
37. Wang,L., Dittmer,D.P., Tomlinson,C.C., Fakhari,F.D. and
Damania,B. (2006) Immortalization of primary endothelial cells
by the K1 protein of Kaposi’s sarcoma-associated herpesvirus.
Cancer Res., 66, 3658–3666.
38. Qian,L.W., Xie,J., Ye,F. and Gao,S.J. (2007) Kaposi’s
sarcoma-associated herpesvirus infection promotes invasion of
primary human umbilical vein endothelial cells by inducing
matrix metalloproteinases. J. Virol., 81, 7001–7010.
39. Rose,P.P., Carroll,J.M., Carroll,P.A., DeFilippis,V.R.,
Lagunoff,M., Moses,A.V., Roberts,C.T. Jr. and Fruh,K. (2007)
The insulin receptor is essential for virus-induced tumorigenesis of
Kaposi’s sarcoma. Oncogene, 26, 1995–2005.
40. Yamamoto,Y., Irie,K., Asada,M., Mino,A., Mandai,K. and
Takai,Y. (2004) Direct binding of the human homologue of the
Drosophila disc large tumor suppressor gene to seven-pass
transmembrane proteins, tumor endothelial marker 5 (TEM5),
and a novel TEM5-like protein. Oncogene, 23, 3889–3897.
41. Graef,I.A., Chen,F., Chen,L., Kuo,A. and Crabtree,G.R. (2001)
Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern
the developing vasculature. Cell, 105, 863–875.
42. Kwapiszewska,G., Wygrecka,M., Marsh,L.M., Schmitt,S.,
Trosser,R., Wilhelm,J., Helmus,K., Eul,B., Zakrzewicz,A.,
Ghofrani,H.A. et al. (2008) Fhl-1, a new key protein in
pulmonary hypertension. Circulation, 118, 1183–1194.
43. Wang,L., Tang,H., Thayanithy,V., Subramanian,S., Oberg,A.L.,
Cunningham,J.M., Cerhan,J.R., Steer,C.J. and Thibodeau,S.N.
(2009) Gene networks and microRNAs implicated in aggressive
prostate cancer. Cancer Res., 69, 9490–9497.
44. Huh,S.H. and Ornitz,D.M. (2010) Beta-catenin deﬁciency causes
DiGeorge syndrome-like phenotypes through regulation of Tbx1.
Development, 137, 1137–1147.
45. Ho,P.J., Yen,M.L., Lin,J.D., Chen,L.S., Hu,H.I., Yeh,C.K.,
Peng,C.Y., Lin,C.Y., Yet,S.F. and Yen,B.L. (2010) Endogenous
KLF4 expression in human fetal endothelial cells allows for
reprogramming to pluripotency with just OCT3/4 and SOX2–brief
report. Arterioscler. Thromb. Vasc. Biol., 30, 1905–1907.
6984 Nucleic Acids Research, 2011,Vol.39, No. 1646. Ben-Porath,I., Thomson,M.W., Carey,V.J., Ge,R., Bell,G.W.,
Regev,A. and Weinberg,R.A. (2008) An embryonic stem cell-like
gene expression signature in poorly differentiated aggressive
human tumors. Nat. Genet., 40, 499–507.
47. Tsai,Y.H., Wu,M.F., Wu,Y.H., Chang,S.J., Lin,S.F., Sharp,T.V.
and Wang,H.W. (2009) The M type K15 protein of Kaposi’s
sarcoma-associated herpesvirus regulates microRNA expression
via its SH2-binding motif to induce cell migration and invasion.
J. Virol., 83, 622–632.
48. Poliseno,L., Tuccoli,A., Mariani,L., Evangelista,M., Citti,L.,
Woods,K., Mercatanti,A., Hammond,S. and Rainaldi,G. (2006)
MicroRNAs modulate the angiogenic properties of HUVECs.
Blood, 108, 3068–3071.
49. O’Hara,A.J., Wang,L., Dezube,B.J., Harrington,W.J. Jr.,
Damania,B. and Dittmer,D.P. (2009) Tumor suppressor
microRNAs are underrepresented in primary effusion lymphoma
and Kaposi sarcoma. Blood, 113, 5938–5941.
50. Gregory,R.I. and Shiekhattar,R. (2005) MicroRNA biogenesis
and cancer. Cancer Res., 65, 3509–3512.
51. Wang,Z., Gerstein,M. and Snyder,M. (2009) RNA-Seq: a
revolutionary tool for transcriptomics. Nat. Rev. Genet., 10,
57–63.
52. Byun,M., Abhyankar,A., Lelarge,V., Plancoulaine,S., Palanduz,A.,
Telhan,L., Boisson,B., Picard,C., Dewell,S., Zhao,C. et al. (2010)
Whole-exome sequencing-based discovery of STIM1 deﬁciency in
a child with fatal classic Kaposi sarcoma. J. Exp. Med., 207,
2307–2312.
53. Hong,Y.K., Foreman,K., Shin,J.W., Hirakawa,S., Curry,C.L.,
Sage,D.R., Libermann,T., Dezube,B.J., Fingeroth,J.D. and
Detmar,M. (2004) Lymphatic reprogramming of blood vascular
endothelium by Kaposi sarcoma-associated herpesvirus.
Nat. Genet., 36, 683–685.
54. Chandriani,S., Xu,Y. and Ganem,D. (2010) The lytic
transcriptome of Kaposi’s sarcoma-associated herpesvirus reveals
extensive transcription of noncoding regions, including regions
antisense to important genes. J. Virol., 84, 7934–7942.
55. Whichard,Z.L., Sarkar,C.A., Kimmel,M. and Corey,S.J. (2010)
Hematopoiesis and its disorders: a systems biology approach.
Blood, 115, 2339–2347.
56. Johnston,J.B., Rahman,M.M. and McFadden,G. (2007) Strategies
that modulate inﬂammasomes: insights from host-pathogen
interactions. Semin. Immunopathol., 29, 261–274.
57. Gregory,S.M., Davis,B.K., West,J.A., Taxman,D.J.,
Matsuzawa,S., Reed,J.C., Ting,J.P. and Damania,B. (2011)
Discovery of a viral NLR homolog that inhibits the
inﬂammasome. Science, 331, 330–334.
58. Shultz,J.C., Goehe,R.W., Wijesinghe,D.S., Murudkar,C.,
Hawkins,A.J., Shay,J.W., Minna,J.D. and Chalfant,C.E. (2010)
Alternative splicing of caspase 9 is modulated by the
phosphoinositide 3-kinase/Akt pathway via phosphorylation of
SRp30a. Cancer Res., 70, 9185–9196.
59. Seol,D.W. and Billiar,T.R. (1999) A caspase-9 variant missing
the catalytic site is an endogenous inhibitor of apoptosis.
J. Biol. Chem., 274, 2072–2076.
60. Srinivasula,S.M., Ahmad,M., Guo,Y., Zhan,Y., Lazebnik,Y.,
Fernandes-Alnemri,T. and Alnemri,E.S. (1999) Identiﬁcation
of an endogenous dominant-negative short isoform
of caspase-9 that can regulate apoptosis. Cancer Res., 59,
999–1002.
61. Kaiser,S., Park,Y.K., Franklin,J.L., Halberg,R.B., Yu,M.,
Jessen,W.J., Freudenberg,J., Chen,X., Haigis,K., Jegga,A.G. et al.
(2007) Transcriptional recapitulation and subversion of embryonic
colon development by mouse colon tumor models and human
colon cancer. Genome Biol., 8, R131.
62. Hu,M. and Shivdasani,R.A. (2005) Overlapping gene expression
in fetal mouse intestine development and human colorectal
cancer. Cancer Res., 65, 8715–8722.
63. Kho,A.T., Zhao,Q., Cai,Z., Butte,A.J., Kim,J.Y., Pomeroy,S.L.,
Rowitch,D.H. and Kohane,I.S. (2004) Conserved mechanisms
across development and tumorigenesis revealed by a mouse
development perspective of human cancers. Genes Dev., 18,
629–640.
64. Chang,S.J., Wang,T.Y., Tsai,C.Y., Hu,T.F., Chang,M.D. and
Wang,H.W. (2009) Increased epithelial stem cell traits in
advanced endometrial endometrioid carcinoma. BMC Genomics,
10, 613.
65. Liu,R., Li,X., Tulpule,A., Zhou,Y., Scehnet,J.S., Zhang,S.,
Lee,J.S., Chaudhary,P.M., Jung,J. and Gill,P.S. (2010)
KSHV-induced notch components render endothelial
and mural cell characteristics and cell survival. Blood, 115,
887–895.
Nucleic Acids Research, 2011,Vol.39, No. 16 6985